QvalFocus Inc.

QvalFocus Inc.

人才中介

Plainsboro,New Jersey 1,629 位关注者

Focused on Delivering Quality that sets us Apart.

关于我们

QvalFocus: Focused on Delivering Quality that sets us Apart. As a premier professional services organization, we are defined by an unwavering commitment to excellence, offering unparalleled precision in every partnership. Our expertise lies in seamlessly aligning top-tier talent with industry leaders in the dynamic landscapes of Life Sciences and Information Technology. Embark on a collaborative journey with us, where we not only help further the careers of our employees but also help our customers make strides in the Life Sciences and Information Technology Industries with a focus on Quality.

网站
https://qvalfocus.com/
所属行业
人才中介
规模
51-200 人
总部
Plainsboro,New Jersey
类型
私人持股
创立
2024
领域
Quality、Validation、Quality Assurance、Automation Testing、SDET、Data Analysts、Business Analysts、SalesForce、Quality Control、Pharmaceutical Manufacturing、IT Product Development、Computer System Validation、Software Quality Assurance、Medical Device Manufacturing、Medical Device Quality、SAS Programming、Regulatory Affairs、Clinical Data Management和Manual Testing

地点

  • 主要

    666 Plainsboro Rd

    Suite 615

    US,New Jersey,Plainsboro,08536

    获取路线

QvalFocus Inc.员工

动态

  • 查看QvalFocus Inc.的公司主页,图片

    1,629 位关注者

    查看Bala Kishan B的档案,图片

    Sr. Technical Recruiter/Team Lead at QvalFocus Inc | Talent Acquisition Strategist | Connecting Top IT Talent with Leading Opportunities

    At Qvalfocus Inc., we are dedicated to delivering exceptional IT staffing and recruiting solutions tailored to meet your unique business needs. Whether you're in search of skilled developers, data analysts, financial analysts, cloud engineers, or specialists in SAP and PMP, our highly experienced team of IT professionals is ready to contribute to your success. ? Why Choose Qvalfocus? ?? Top-tier IT talent ?? Customized staffing solutions ?? Strong partnerships for long-term success If you're looking for reliable IT talent or have staffing requirements, feel free to reach out: [email protected]. Let’s collaborate to achieve your business goals! #ITStaffing #Recruiting #TechTalent #BusinessSolutions #Qvalfocus #ITProfessionals #SAP #PMP #DataAnalytics #CloudEngineering #SoftwareDevelopment #SFDC #SFDCArchitect #Seniors #Lead #USA

    • 该图片无替代文字
  • 查看QvalFocus Inc.的公司主页,图片

    1,629 位关注者

    查看ASQ Chicago Training Institute的公司主页,图片

    700 位关注者

    We want to take this opportunity to thank our Summit Sponsors. Their generous contributions help further our mission to provide enhanced expertise, professional networks, tools, training and solutions. Thank you to: Veeva MedTech Revalize Oneus technologies ValGenesis ASQ East North Central Section QRx Partners MoreSteam PIVOT Management Consultants QvalFocus Inc. Register today for the Innovate for Excellence Summit-Chicago (https://lnkd.in/gg2Xizic)

    • 该图片无替代文字
  • 查看QvalFocus Inc.的公司主页,图片

    1,629 位关注者

    查看Charmi V的档案,图片

    Talent Acquisition @ QvalFocus | Connecting Top Talent with Top Companies in Life Sciences space

    #wearehiring We (#QvalFocus) are looking for a?Calibration & Maintenance Specialist who can join Immediately for one of our clients in New Jersey. Job Role: Calibration & Maintenance Specialist Location: Parsippany, NJ Duration: 6+ Months We are looking for a Calibration & Maintenance Specialist to help our Pharmaceutical Client (Oral Solid Dosage Manufacturer) in the cGMP Manufacturing Environment. The Calibration & Maintenance Specialist is responsible for driving the Calibration & Maintenance program in the cGMP areas for API manufacturing. Job Responsibilities: ? Perform regular maintenance and calibration of key manufacturing equipment, including tablet presses, fluid bed dryers, and other Manufacturing Equipment, Utility, and Facility systems ensuring compliance with cGMP standards and regulatory requirements. ? Diagnose and repair mechanical, electrical, and control system issues on production equipment like chromatography skid systems, coating machines and other equipment minimizing production downtime. ? Maintain comprehensive and accurate records of maintenance and calibration activities, including schedules, procedures, and outcomes, in accordance with company policies and regulatory standards. ? Work closely with production and quality assurance teams to coordinate maintenance activities, ensuring minimal disruption to manufacturing processes. ? Develop and implement preventive maintenance programs for equipment such as granulators (e.g., GEA) and encapsulation machines (e.g., Bosch), aiming to extend equipment lifespan and enhance reliability. ? Conduct regular inspections and tests on equipment to verify proper operation and calibration, ensuring accuracy, consistency, and adherence to quality standards. ? Oversee the management of spare parts inventory, coordinating with suppliers to ensure the availability of necessary components for timely maintenance and repairs. ? Participate in the installation and qualification of new equipment, providing technical support and ensuring all validation protocols and compliance requirements are met. #QvalFocusJobs #hiring #CalibrationMaintenanceSpecialist

  • 查看QvalFocus Inc.的公司主页,图片

    1,629 位关注者

    查看Charmi V的档案,图片

    Talent Acquisition @ QvalFocus | Connecting Top Talent with Top Companies in Life Sciences space

    #wearehiring We (#QvalFocus) are looking for an Investigations Specialist who can join Immediately for one of our clients in New Jersey. Job Role: Investigations Specialist ??Location: Parsippany, NJ ?Duration: 6+ Months We are looking for an Investigator to help our Pharmaceutical Client (Oral Solid Dosage Manufacturer) in the Manufacturing Environment. The Deviation Investigator is responsible for investigating deviations to the manufacturing process and other operational problems cGMP areas for API manufacturing. Job Responsibilities: ? Investigate manufacturing process failures and non-conformances independently to prevent reoccurrences. ? Prepare and present investigation reports with recommendations for medium/high severity non-conformances. ? Analyze investigation data, summarize findings, and identify trends. ? Collaborate with cross-functional teams (manufacturing, QC, Facilities, MSAT, process engineering) to resolve deviations and compliance discrepancies. ? Lead cross-functional teams to identify root causes, assess technical impacts, and recommend batch dispositions. ? Ensure timely completion of deviation investigations and consistent reporting for regulatory inspections. ? Monitor production processes to collect data supporting investigations and track efficiency improvements. ? Initiate and oversee corrective and preventive actions (CAPAs) to address deviations and prevent recurrence. ? Communicate investigation status, findings, and recommendations effectively with peers and stakeholders. ? Provide oversight for technically challenging investigations and manage multiple investigations simultaneously. If you or anyone you know is interested, please message me! ? (or) Kindly send your resume to [email protected]. #QvalFocus #QvalFocusJobs #hiring #InvestigationSpecialist #pharma #pharmaceutical #PharmaceuticalJobs

  • 查看QvalFocus Inc.的公司主页,图片

    1,629 位关注者

    查看Anil Nalluri的档案,图片

    Co-Founder & Director of Sales and Client Services at QvalFocus Inc.

    *CAR-T (Chimeric Antigen Receptor T-cell) Therapy* CAR-T Therapy, is a novel treatment that modifies a patient's T-cells (T-cells are a type of white blood cell called lymphocytes) to specifically target and destroy certain blood cancers. Researchers are working to make these therapies more effective and safer by using advanced genetic engineering techniques, like adding dual-targeting receptors and safety switches. *Reducing Relapse & Toxic Reactions has been the current focus* Follow us QvalFocus Inc. for latest trends and jobs in the Industry. #CART #Beginnersread #NovelTherapies #Biologics #FutureOfMedicine #QvalFocus https://lnkd.in/eR83bNEA.

    CAR-T cell therapy: Where are we now, and where are we heading?

    CAR-T cell therapy: Where are we now, and where are we heading?

    ncbi.nlm.nih.gov

  • QvalFocus Inc.转发了

    查看Naina M的档案,图片

    Business Development Consultant @ QvalFocus Inc. | Business Development Support, Advertising

    The approval of interchangeable biosimilars to Regeneron's Eylea marks a milestone in the field of biosimilars and could potentially bring more affordable options to patients in need of treatments for conditions like macular degeneration. This development not only expands treatment options but also fosters competition in the market, which often leads to lower costs and increased accessibility for patients. #FDA #BIOSIMILAR'S #REGENERON'S #QVALFOCUS

    查看Hung Trinh的档案,图片

    Sr. Director, Cell & Gene Therapies, Vaccine

    FDA approves first two interchangeable biosimilars to Regeneron's blockbuster Eylea Eylea will eventually have competition in the US, as the FDA approved two interchangeable biosimilars. Monday’s approvals for Biocon Biologics’ Yesafili and Samsung Bioepis and Biogen’s Opuviz are based on the companies’ ability to show that their aflibercept competitors have no clinically meaningful differences from brand-name Eylea. Yesafili won approval in the UK last November and in Europe last September. “This evidence included comparisons of each product to Eylea on an analytical level using an extensive and robust battery of physicochemical tests and biological assays, and in a comparative clinical study in patients,” FDA said in announcing the approvals. Sandoz also has another Eylea biosimilar in the works. While most interchangeable biosimilars have to run switching studies to win approval, FDA confirmed to Endpoints that neither interchangeable for Eylea had to run such studies. The agency said “the risk of a clinically impactful immunogenic response when alternating or switching between Yesafili and Eylea or Opuviz and Eylea is low. Thus, a switching study that compares immunogenic responses to assess whether the risk of alternating or switching between Yesafili and Eylea or Opuviz and Eylea were unnecessary for either product.” But because of remaining patents on Eylea, analysts don’t expect either of the two new biosimilars to launch until 2027. In August, Regeneron also launched a high-dose version of Eylea that it hopes will become the standard of care in several retinal diseases. In its first-quarter filing, Regeneron recorded $200 million in US sales of the high-dose version, and about $2.3 billion in worldwide sales of Eylea and Eylea HD. Competition from interchangeable biosimilars is increasing for some of the biggest drugs in the world, including AbbVie’s Humira. Regeneron reported more than $12 billion in Eylea sales in 2022 and 2023. Eylea may also be up for Medicare negotiations in the next few years — in 2022, Medicare Part B spent more money on Eylea than any other drug except Merck’s Keytruda. https://lnkd.in/eSRuCBTs

    FDA approves first two interchangeable biosimilars to Regeneron’s blockbuster Eylea

    FDA approves first two interchangeable biosimilars to Regeneron’s blockbuster Eylea

    https://endpts.com

相似主页